A T cell-specific deletion of HDAC1 protects against experimental autoimmune encephalomyelitis. 2018

Lisa Göschl, and Teresa Preglej, and Patricia Hamminger, and Michael Bonelli, and Liisa Andersen, and Nicole Boucheron, and Alexandra F Gülich, and Lena Müller, and Victoria Saferding, and Ilgiz A Mufazalov, and Kiyoshi Hirahara, and Christian Seiser, and Patrick Matthias, and Thomas Penz, and Michael Schuster, and Christoph Bock, and Ari Waisman, and Günter Steiner, and Wilfried Ellmeier
Division of Immunobiology, Institute of Immunology, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, 1090 Vienna, Austria; Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, 1090 Vienna, Austria.

Multiple sclerosis (MS) is a human neurodegenerative disease characterized by the invasion of autoreactive T cells from the periphery into the CNS. Application of pan-histone deacetylase inhibitors (HDACi) ameliorates experimental autoimmune encephalomyelitis (EAE), an animal model for MS, suggesting that HDACi might be a potential therapeutic strategy for MS. However, the function of individual HDAC members in the pathogenesis of EAE is not known. In this study we report that mice with a T cell-specific deletion of HDAC1 (using the Cd4-Cre deleter strain; HDAC1-cKO) were completely resistant to EAE despite the ability of HDAC1cKO CD4+ T cells to differentiate into Th17 cells. RNA sequencing revealed STAT1 as a prominent upstream regulator of differentially expressed genes in activated HDAC1-cKO CD4+ T cells and this was accompanied by a strong increase in phosphorylated STAT1 (pSTAT1). This suggests that HDAC1 controls STAT1 activity in activated CD4+ T cells. Increased pSTAT1 levels correlated with a reduced expression of the chemokine receptors Ccr4 and Ccr6, which are important for the migration of T cells into the CNS. Finally, EAE susceptibility was restored in WT:HDAC1-cKO mixed BM chimeric mice, indicating a cell-autonomous defect. Our data demonstrate a novel pathophysiological role for HDAC1 in EAE and provide evidence that selective inhibition of HDAC1 might be a promising strategy for the treatment of MS.

UI MeSH Term Description Entries
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002678 Chimera An individual that contains cell populations derived from different zygotes. Hybrids,Chimeras,Hybrid
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004681 Encephalomyelitis, Autoimmune, Experimental An experimental animal model for central nervous system demyelinating disease. Inoculation with a white matter emulsion combined with FREUND'S ADJUVANT, myelin basic protein, or purified central myelin triggers a T cell-mediated immune response directed towards central myelin. The pathologic features are similar to MULTIPLE SCLEROSIS, including perivascular and periventricular foci of inflammation and demyelination. Subpial demyelination underlying meningeal infiltrations also occurs, which is also a feature of ENCEPHALOMYELITIS, ACUTE DISSEMINATED. Passive immunization with T-cells from an afflicted animal to a normal animal also induces this condition. (From Immunol Res 1998;17(1-2):217-27; Raine CS, Textbook of Neuropathology, 2nd ed, p604-5) Autoimmune Encephalomyelitis, Experimental,Encephalomyelitis, Allergic,Encephalomyelitis, Experimental Autoimmune,Allergic Encephalomyelitis,Allergic Encephalomyelitis, Experimental,Autoimmune Experimental Encephalomyelitis,Experimental Allergic Encephalomyelitis,Experimental Autoimmune Encephalomyelitis,Encephalomyelitis, Autoimmune Experimental,Encephalomyelitis, Experimental Allergic,Experimental Allergic Encephalomyelitides,Experimental Encephalomyelitis, Autoimmune
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D050794 STAT1 Transcription Factor A signal transducer and activator of transcription that mediates cellular responses to INTERFERONS. Stat1 interacts with P53 TUMOR SUPPRESSOR PROTEIN and regulates expression of GENES involved in growth control and APOPTOSIS. Gamma-Activated Factor, 91 kDa,STAT-91 Protein,STAT-91 Transcription Factor,STAT1 Protein,STAT91 Transcription Factor,Signal Transducer and Activator of Transcription 1,Transcription Factor STAT91,Gamma Activated Factor, 91 kDa,STAT 91 Protein,STAT 91 Transcription Factor,Transcription Factor, STAT-91,Transcription Factor, STAT1,Transcription Factor, STAT91
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

Lisa Göschl, and Teresa Preglej, and Patricia Hamminger, and Michael Bonelli, and Liisa Andersen, and Nicole Boucheron, and Alexandra F Gülich, and Lena Müller, and Victoria Saferding, and Ilgiz A Mufazalov, and Kiyoshi Hirahara, and Christian Seiser, and Patrick Matthias, and Thomas Penz, and Michael Schuster, and Christoph Bock, and Ari Waisman, and Günter Steiner, and Wilfried Ellmeier
February 2007, Journal of immunology (Baltimore, Md. : 1950),
Lisa Göschl, and Teresa Preglej, and Patricia Hamminger, and Michael Bonelli, and Liisa Andersen, and Nicole Boucheron, and Alexandra F Gülich, and Lena Müller, and Victoria Saferding, and Ilgiz A Mufazalov, and Kiyoshi Hirahara, and Christian Seiser, and Patrick Matthias, and Thomas Penz, and Michael Schuster, and Christoph Bock, and Ari Waisman, and Günter Steiner, and Wilfried Ellmeier
December 2001, The Journal of experimental medicine,
Lisa Göschl, and Teresa Preglej, and Patricia Hamminger, and Michael Bonelli, and Liisa Andersen, and Nicole Boucheron, and Alexandra F Gülich, and Lena Müller, and Victoria Saferding, and Ilgiz A Mufazalov, and Kiyoshi Hirahara, and Christian Seiser, and Patrick Matthias, and Thomas Penz, and Michael Schuster, and Christoph Bock, and Ari Waisman, and Günter Steiner, and Wilfried Ellmeier
May 2011, Journal of neuroimmunology,
Lisa Göschl, and Teresa Preglej, and Patricia Hamminger, and Michael Bonelli, and Liisa Andersen, and Nicole Boucheron, and Alexandra F Gülich, and Lena Müller, and Victoria Saferding, and Ilgiz A Mufazalov, and Kiyoshi Hirahara, and Christian Seiser, and Patrick Matthias, and Thomas Penz, and Michael Schuster, and Christoph Bock, and Ari Waisman, and Günter Steiner, and Wilfried Ellmeier
October 1989, Nature,
Lisa Göschl, and Teresa Preglej, and Patricia Hamminger, and Michael Bonelli, and Liisa Andersen, and Nicole Boucheron, and Alexandra F Gülich, and Lena Müller, and Victoria Saferding, and Ilgiz A Mufazalov, and Kiyoshi Hirahara, and Christian Seiser, and Patrick Matthias, and Thomas Penz, and Michael Schuster, and Christoph Bock, and Ari Waisman, and Günter Steiner, and Wilfried Ellmeier
January 2020, Oxidative medicine and cellular longevity,
Lisa Göschl, and Teresa Preglej, and Patricia Hamminger, and Michael Bonelli, and Liisa Andersen, and Nicole Boucheron, and Alexandra F Gülich, and Lena Müller, and Victoria Saferding, and Ilgiz A Mufazalov, and Kiyoshi Hirahara, and Christian Seiser, and Patrick Matthias, and Thomas Penz, and Michael Schuster, and Christoph Bock, and Ari Waisman, and Günter Steiner, and Wilfried Ellmeier
April 2013, The Journal of neuroscience : the official journal of the Society for Neuroscience,
Lisa Göschl, and Teresa Preglej, and Patricia Hamminger, and Michael Bonelli, and Liisa Andersen, and Nicole Boucheron, and Alexandra F Gülich, and Lena Müller, and Victoria Saferding, and Ilgiz A Mufazalov, and Kiyoshi Hirahara, and Christian Seiser, and Patrick Matthias, and Thomas Penz, and Michael Schuster, and Christoph Bock, and Ari Waisman, and Günter Steiner, and Wilfried Ellmeier
February 2022, Journal of neuroinflammation,
Lisa Göschl, and Teresa Preglej, and Patricia Hamminger, and Michael Bonelli, and Liisa Andersen, and Nicole Boucheron, and Alexandra F Gülich, and Lena Müller, and Victoria Saferding, and Ilgiz A Mufazalov, and Kiyoshi Hirahara, and Christian Seiser, and Patrick Matthias, and Thomas Penz, and Michael Schuster, and Christoph Bock, and Ari Waisman, and Günter Steiner, and Wilfried Ellmeier
February 2015, Journal of immunology (Baltimore, Md. : 1950),
Lisa Göschl, and Teresa Preglej, and Patricia Hamminger, and Michael Bonelli, and Liisa Andersen, and Nicole Boucheron, and Alexandra F Gülich, and Lena Müller, and Victoria Saferding, and Ilgiz A Mufazalov, and Kiyoshi Hirahara, and Christian Seiser, and Patrick Matthias, and Thomas Penz, and Michael Schuster, and Christoph Bock, and Ari Waisman, and Günter Steiner, and Wilfried Ellmeier
July 2015, Journal of immunology (Baltimore, Md. : 1950),
Lisa Göschl, and Teresa Preglej, and Patricia Hamminger, and Michael Bonelli, and Liisa Andersen, and Nicole Boucheron, and Alexandra F Gülich, and Lena Müller, and Victoria Saferding, and Ilgiz A Mufazalov, and Kiyoshi Hirahara, and Christian Seiser, and Patrick Matthias, and Thomas Penz, and Michael Schuster, and Christoph Bock, and Ari Waisman, and Günter Steiner, and Wilfried Ellmeier
June 2013, Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology,
Copied contents to your clipboard!